<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>ALTRENOGEST- altrenogest solution </strong><br>Ceva Santé Animale<br></p></div>
<h1></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_c201844a-4d21-4745-bd0a-079140213d2b"></a><a name="section-1"></a><p></p>
<p class="First"><span class="Bold">Altrenogest Solution</span></p>
<p><span class="Bold">(altrenogest)</span></p>
<p>SOLUTION 0.22%</p>
<p>(2.2 mg/mL)</p>
<p><span class="Bold">FOR ORAL USE IN ANIMALS ONLY</span></p>
<p><span class="Bold">Drug Facts:</span></p>
<p><span class="Bold">Active ingredients:</span> Altrenogest Solution 0.22% (2.2 mg/mL)</p>
<p><span class="Bold">Use:</span> For synchronization of estrus in sexually mature gilts that have had at least one estrous cycle. Treatment with altrenogest solution 0.22% results in estrus (standing heat) 4 to 9 days after completion of the 14-day treatment period.</p>
<p><span class="Bold">Caution:</span> Federal law prohibits extra-label use of this drug to enhance food and/or fiber production in animals.</p>
<p><span class="Bold">Do Not Use:</span> In gilts having a previous or current history of <span class="product-label-link" type="condition" conceptid="4035007" conceptname="Metritis">uterine inflammation</span> (i.e., acute, subacute or chronic <span class="product-label-link" type="condition" conceptid="4302765" conceptname="Endometritis">endometritis</span>).</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="L6f44d11e-7e81-4907-8121-a92b7850f662"></a><a name="section-2"></a><p></p>
<h1>WARNINGS</h1>
<p class="First"><span class="Bold">Keep this and all medication out of the </span><span class="Bold">reach of children.</span></p>
<p><span class="Bold">User/Handler Safety:</span> Avoid skin contact. Wear vinyl, neoprene or nitrile protective gloves when handling this product. <span class="Bold">DO NOT USE LATEX GLOVES</span></p>
<p><span class="Underline">Pregnant women or women who suspect they are pregnant should not handle altrenogest solution 0.22%.</span> Women of childbearing age should exercise extreme caution when handling this product. Accidental absorption could lead to a disruption of the menstrual cycle or prolongation of pregnancy. Wash off accidental spillage on the skin immediately with soap and water.</p>
<p><span class="Bold">People who should not handle this product:</span></p>
<p><span class="Bold">1.</span> Women who are or suspect they are pregnant.</p>
<p><span class="Bold">2.</span> Anyone with <span class="product-label-link" type="condition" conceptid="320741" conceptname="Thrombophlebitis">thrombophlebitis</span> or thromboembolic disorders or with a history of these events.</p>
<p><span class="Bold">3.</span> Anyone with cerebral-vascular or coronary-artery disease.</p>
<p><span class="Bold">4.</span> Women with known or suspected carcinoma of the breast.</p>
<p><span class="Bold">5.</span> People with known or suspected estrogendependent neoplasia.</p>
<p><span class="Bold">6.</span> Women with undiagnosed <span class="product-label-link" type="condition" conceptid="4129155" conceptname="Vaginal bleeding">vaginal bleeding</span>.</p>
<p><span class="Bold">7.</span> People with benign or <span class="product-label-link" type="condition" conceptid="197506" conceptname="Malignant neoplasm of abdomen">malignant tumors</span> which developed during the use of oral contraceptives or other estrogen-containing products.</p>
<p><span class="Bold">8.</span> Anyone with liver dysfunction or disease.</p>
<p><span class="Bold">Accidental exposure:</span> Altrenogest is readily absorbed from contact with the skin. In addition, this oil based product can penetrate porous gloves. Altrenogest should not penetrate <span class="Underline">intact</span> vinyl, neoprene or nitrile protective gloves; however, if there is leakage (i.e., pinhole, spillage, etc.) the contaminated area covered by such occlusive materials may have increased absorption. <span class="Bold">DO NOT USE LATEX GLOVES</span></p>
<p><span class="Bold">The following measures are recommended in case of accidental exposure.</span></p>
<p><span class="Underline"><span class="Bold">Skin Exposure:</span></span> Wash immediately with soap and water.</p>
<p><span class="Underline"><span class="Bold">Eye Exposure:</span></span> Immediately flush with plenty of water for 15 minutes. Get medical attention.</p>
<p><span class="Underline"><span class="Bold">If Swallowed:</span></span>Do not induce <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>.</p>
<p>Altrenogest solution 0.22% contains an oil. Call a physician. <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">Vomiting</span> should be supervised by a physician because of possible pulmonary damage via <span class="product-label-link" type="condition" conceptid="4239038" conceptname="Pulmonary aspiration">aspiration</span> of the oil base. If possible, bring the container and labeling to the physician.</p>
<p><span class="Bold">Effects of Overexposure:</span> There has been no human use of this specific product. The information contained in this section is extrapolated from data available on other products of the same pharmacological class that have been used in humans. Effects anticipated are due to the progestational activity of altrenogest. Acute effects after a single exposure are possible; however, continued daily exposure has the potential for more untoward effects such as disruption of the menstrual cycle, uterine or abdominal cramping, increased or decreased <span class="product-label-link" type="condition" conceptid="195876" conceptname="Hematometra">uterine bleeding</span>, prolongation of pregnancy and <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headaches</span>. The oil base may also cause complications if swallowed. In addition, the list of people who should not handle this product is based upon the known effects of progestins used in humans on a chronic basis.</p>
</div>
<div class="Section" data-sectionCode="50743-4">
<a name="Le5ad3751-39d6-4ef2-bde6-0bf50329d73d"></a><a name="section-3"></a><p></p>
<p class="First"><span class="Bold">Human Food Safety: </span>Gilts must not be slaughtered for human consumption for 21 days after the last treatment.</p>
</div>
<div class="Section" data-sectionCode="50742-6">
<a name="L9e9c3850-1cb2-43b3-ba36-40401018c5d8"></a><a name="section-4"></a><p></p>
<p class="First"><span class="Bold">Environmental Safety:</span> Place empty drug containers and used syringes, protective gloves or other articles that come in contact with this product in a leak-resistant container for disposal in accordance with applicable Federal, state and local regulations.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="Ldca2d329-4a3f-4c9d-b8db-907cb24fe5a3"></a><a name="section-5"></a><p></p>
<p class="First"><span class="Bold">Adverse Reactions and Potential Safety Hazards:</span> Underfeeding of Altrenogest Solution may lead to the occurrence of cystic follicles.</p>
<p><span class="Bold">When Using This Product:</span> A small percentage (less than 5%) of treated gilts may exhibit estrus (standing heat) during the 14-day treatment period. Gilts nearing estrus at the start of the 14-day treatment period may express estrus early in that period.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_indications_id_8d33ac34-f932-41e0-aa7d-465368c35560"></a><a name="section-6"></a><p></p>
<p class="First"><span class="Bold">Dosage and Directions:</span> While wearing protective gloves, remove shipping cap and seal; replace with enclosed plastic dispensing cap. Remove cover from bottle dispensing tip and connect luer lock syringe (without needle). Draw out appropriate volume of Altrenogest Solution. (Note: Do not remove syringe while bottle is inverted as spillage may result.) Detach syringe and replace cover on bottle dispensing tip to prevent leakage. Administer 6.8 mL (15 mg altrenogest) per gilt once daily for 14 consecutive days. Treat gilts on an individual animal basis by top-dressing Altrenogest Solution on a portion of each gilt’s daily feed allowance. To produce the desired synchronization of estrus in a group of gilts, treat all of the gilts daily for the same 14-day period. Excessive use of a syringe may cause the syringe to stick; therefore, replace syringe as necessary.</p>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="i4i_how_supplied_id_1d1eb32f-7309-4d30-bc57-cc8e989f2db4"></a><a name="section-7"></a><p></p>
<p class="First"><span class="Bold">Other Information:</span></p>
<p><span class="Bold">Storage:</span> Store at or below room temperature, 77°F (25°C). Close tightly.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="Ld8d49b29-c9a1-48c3-8baa-c432367f8852"></a><a name="section-8"></a><p></p>
<p class="First"><span class="Bold">Questions? Comments?</span></p>
<p>- To report a suspected adverse reaction, call 1-800-999-0297.</p>
<p>- To obtain product information, including material safety data sheet (MSDS), call 1-800-999-0297.</p>
<p><span class="Bold">Manufactured for:</span></p>
<p>Ceva Santé Animale, Libourne, France</p>
<p><span class="Bold">Marketed by:</span></p>
<p>Ceva Animal Health, LLC Lenexa, KS 66215</p>
<p>ANADA # 200-579, Approved by FDA</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_cbc7e1a9-35f7-4a92-b980-9da6815aee7e"></a><a name="section-9"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 1000 mL BOTTLE</h1>
<p class="First"><span class="Bold">Altrenogest Solution</span></p>
<p><span class="Bold">(altrenogest)</span></p>
<p><span class="Bold">FOR ORAL USE IN ANIMALS ONLY</span></p>
<p><span class="Bold">Drug Facts:</span></p>
<p><span class="Bold">Active ingredients:</span> Altrenogest Solution 0.22% (2.2 mg/mL)</p>
<p><span class="Bold">Use:</span> For synchronization of estrus in sexually mature gilts that have had at least one estrous cycle. Treatment with altrenogest solution 0.22% results in estrus (standing heat) 4 to 9 days after completion of the 14-day treatment period.</p>
<p><span class="Bold">Caution:</span> Federal law prohibits extra-label use of this drug to enhance food and/or fiber production in animals.</p>
<p><span class="Bold">Do Not Use:</span> In gilts having a previous or current history of <span class="product-label-link" type="condition" conceptid="4035007" conceptname="Metritis">uterine inflammation</span> (i.e., acute, subacute or chronic <span class="product-label-link" type="condition" conceptid="4302765" conceptname="Endometritis">endometritis</span>).</p>
<p><span class="Bold">Net Contents: 1000 mL</span></p>
<p><span class="Bold">Restricted Drug (California) – use only as directed.</span></p>
<p><span class="Bold">Not for Human Use</span></p>
<p><span class="Bold">Keep this and all medication out of the reach of children.</span></p>
<p><span class="Bold"></span></p>
<p><img alt="1000 mL Bottle" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4b096dd1-fc17-4db6-8e6d-33413de821e5&amp;name=1000mLBottle.jpg"></p>
<p class="MultiMediaCaption"></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>ALTRENOGEST 		
					</strong><br><span class="contentTableReg">altrenogest solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">OTC ANIMAL DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:13744-515</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>ALTRENOGEST</strong> (ALTRENOGEST) </td>
<td class="formItem">ALTRENOGEST</td>
<td class="formItem">2.2 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">YELLOW (Light) </td>
<td class="formLabel">Score</td>
<td class="formItem">    </td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem"></td>
<td class="formLabel">Size</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:13744-515-10</td>
<td class="formItem">1000 mL in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANADA</td>
<td class="formItem">ANADA200579</td>
<td class="formItem">06/01/2015</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Ceva Santé Animale
							(261126049)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 5/2015<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>6500f5c5-2618-4757-bbe8-be800f56f3d9</div>
<div>Set id: 4b096dd1-fc17-4db6-8e6d-33413de821e5</div>
<div>Version: 1</div>
<div>Effective Time: 20150519</div>
</div>
</div> <div class="DistributorName">Ceva Santé Animale</div></p>
</body></html>
